18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3513<br />

MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

(51) (97) (54)<br />

A61K 9/20 (2006.01) EP 2089002 * PHENYLALKYL CARBAMATE COMPOSITIONS<br />

A61K 9/20 (2006.01) EP 2<strong>09</strong>9430 * PH SENSITIVE MATRIX FORMULATION<br />

A61K 9/32 (2006.01) EP 2<strong>09</strong>4261 * PHARMACEUTICAL COMPOSITION CONTAINING NAPHTHOQUINONE-BASED<br />

COMPOUND FOR INTESTINE DELIVERY SYSTEM<br />

A61K 9/32 (2006.01) EP 2<strong>09</strong>4262 * PHARMACEUTICAL COMPOSITION CONTAINING PHENANTHRENEQUINONE-BASED<br />

COMPOUND FOR INTESTINE DELIVERY SYSTEM<br />

A61K 9/70 (2006.01) EP 2<strong>09</strong>0310 * ADHESIVE PREPARATION, AND METHOD FOR REDUCING THE PRODUCTION OF<br />

DONEPEZIL ANALOGUE IN DONEPEZIL-CONTAINING SKIN ADHESIVE PREPARATION<br />

METHOD FOR PREVENTION OF COLORATION IN DONEPEZIL-CONTAINING SKIN<br />

A61K 9/70 (2006.01) EP 2<strong>09</strong>1541 * VAGINAL DELIVERY SYSTEM FOR MIRTAZAPINE<br />

A61K 9/70 (2006.01) EP 2<strong>09</strong>8232 * PERCUTANEOUS ABSORPTION PREPARATION<br />

A61K 9/70 (2006.01) EP 2<strong>09</strong>8233 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 9/70 (2006.01) EP 2<strong>09</strong>8234 * SKIN ADHESIVE PREPARATION COMPRISING STABILIZED DONEPEZIL<br />

A61K 9/70 (2006.01) EP 2<strong>09</strong>8235 * METHOD FOR PREVENTION OF DISCOLORATION WITH TIME OF DONEPEZIL-<br />

CONTAINING SKIN ADHESIVE PREPARATION<br />

A61L 15/00 (2006.01) EP 2<strong>09</strong>7113 * COMPRESSION WRAP<br />

A61L 27/38 (2006.01) EP 2<strong>09</strong>95<strong>09</strong> * METHODS&COMPOSITIONS FOR TREATING TISSUE USING SILK PROTEINS<br />

A61L 27/48 (2006.01) EP 2089075 * MATRIX GEL GRAFT WITHOUT CELLS<br />

A61L 27/48 (2006.01) EP 2<strong>09</strong>95<strong>09</strong> * METHODS&COMPOSITIONS FOR TREATING TISSUE USING SILK PROTEINS<br />

A61L 27/52 (2006.01) EP 2<strong>09</strong>95<strong>09</strong> * METHODS&COMPOSITIONS FOR TREATING TISSUE USING SILK PROTEINS<br />

A61L 27/56 (2006.01) EP 2089075 * MATRIX GEL GRAFT WITHOUT CELLS<br />

A61L 27/58 (2006.01) EP 2089075 * MATRIX GEL GRAFT WITHOUT CELLS<br />

A61L 29/16 (2006.01) EP 2086602 * DRUG RELEASING COATINGS FOR MEDICAL DEVICES<br />

A61L 29/16 (2006.01) EP 2<strong>09</strong>2941 Drug releasing coatings for medical devices<br />

A61L 29/16 (2006.01) EP 2<strong>09</strong>2942 Drug releasing coatings for medical devices<br />

A61L 31/16 (2006.01) EP 2086602 * DRUG RELEASING COATINGS FOR MEDICAL DEVICES<br />

A61L 31/16 (2006.01) EP 2<strong>09</strong>2942 Drug releasing coatings for medical devices<br />

A61M 11/04 (2006.01) EP 2<strong>09</strong>6374 Self-contained heating unit and drug-supply unit employing same<br />

A61M 15/00 (2006.01) EP 2011538 Inhaler<br />

A61M 15/00 (2006.01) EP 2<strong>09</strong>1602 * SHEET DRIVER FOR USE IN A DRUG DISPENSER<br />

A61M 15/00 (2006.01) EP 2<strong>09</strong>4224 * CAPSULE, FILLED WITH A MEDICINE, IN PARTICULAR AN INHALABLE MEDICINE<br />

A61M 15/00 (2006.01) EP 2<strong>09</strong>9514 * DOSE COUNTER MECHANISM<br />

A61M 15/06 (2006.01) EP 2<strong>09</strong>6374 Self-contained heating unit and drug-supply unit employing same<br />

A61M 25/00 (2006.01) EP 2086511 * POLYMER-BASED ANTIMICROBIAL AGENTS, METHODS OF MAKING SAID AGENTS, AND<br />

PRODUCTS AND APPLICATIONS USING SAID AGENTS<br />

A61M 25/00 (2006.01) EP 2086571 * TISSUE PLASMINOGEN ACTIVATOR VARIANT USES<br />

A61M 25/02 (2006.01) EP 2089081 * INFUSION SET<br />

A61M 31/00 (2006.01) EP 2<strong>09</strong>4348 * DELIVERY SYSTEM FOR A NON-STEROIDAL NON-IONIZED HYDROPHILIC DRUG<br />

A61M 31/00 (2006.01) EP 2<strong>09</strong>7044 * DRUG DELIVERY IMPLANTS FOR INHIBITION OF OPTICAL DEFECTS<br />

A61M 35/00 (2006.01) EP 2<strong>09</strong>7044 * DRUG DELIVERY IMPLANTS FOR INHIBITION OF OPTICAL DEFECTS<br />

A61M 37/00 (2006.01) EP 2<strong>09</strong>4349 * TOPICAL NITRIC OXIDE AS A TREATMENT OF AUTOIMMUNE DISEASES<br />

A61M 37/00 (2006.01) EP 2<strong>09</strong>7062 * WIDE-AREA PARASYSTEMIC TREATMENT OF SKIN RELATED CONDITIONS<br />

A61M 39/10 (2006.01) EP 2089081 * INFUSION SET<br />

A61M 39/12 (2006.01) EP 2077128 Injection Device<br />

A61M 5/00 (2006.01) EP 2086466 * AN IMPLANTABLE FLUID MANAGEMENT DEVICE FOR THE REMOVAL OF EXCESS FLUID<br />

A61M 5/00 (2006.01) EP 2<strong>09</strong>4332 * MULTIPLE FLUID DELIVERY DEVICE FOR POULTRY<br />

A61M 5/142 (2006.01) EP 2077128 Injection Device<br />

A61M 5/158 (2006.01) EP 2077128 Injection Device<br />

A61M 5/158 (2006.01) EP 2089081 * INFUSION SET<br />

A61M 5/30 (2006.01) EP 2<strong>09</strong>1599 * IMPROVEMENTS IN AND RELATING TO DRIVE MECHANISMS SUITABLE FOR USE IN<br />

DRUG DELIVERY DEVICES<br />

A61P 1/00 (2006.01) EP 1886690 Pharmaceutical composition for the treatment of food intolerance<br />

A61P 1/00 (2006.01) EP 2<strong>09</strong>4720 * SELECTIVE INHIBITORS OF NEUROTENSIN DEGRADING ENZYMES<br />

A61P 1/00 (2006.01) EP 2<strong>09</strong>7079 * MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS<br />

A61P 1/16 (2006.01) EP 2<strong>09</strong>1531 * PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR BLOCKING<br />

DEGENERATIVE TISSUE DAMAGES BY INHIBITING MPT<br />

A61P 1/16 (2006.01) EP 2<strong>09</strong>4640 * ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF<br />

THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR).<br />

A61P 1/16 (2006.01) EP 2<strong>09</strong>7378 * NOVEL SEH INHIBITORS AND THEIR USE<br />

A61P 11/00 (2006.01) EP 2<strong>09</strong>4271 * DRUG COMBINATIONS FOR TREATING AIRWAY DISEASES<br />

A61P 11/00 (2006.01) EP 2<strong>09</strong>4646 * AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED<br />

DISEASES<br />

A61P 11/00 (2006.01) EP 2<strong>09</strong>7406 * HYDANTOIN DERIVATIVES USED AS MMP INHIBITORS<br />

A61P 11/00 (2006.01) EP 2<strong>09</strong>7407 * PYRAZOLE ANALOGS<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!